Thoracic Neoplasms  >>  Imjudo (tremelimumab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Imjudo (tremelimumab) / AstraZeneca, Pfizer
GEFTREM, NCT02040064: Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients

Checkmark ESMO 2016
Oct 2016 - Oct 2016: ESMO 2016
Checkmark AACR-NCI-EORTC 2015
Oct 2015 - Oct 2015: AACR-NCI-EORTC 2015
Completed
1
27
Europe
Gefitinib, Tremelimumab
Gustave Roussy, Cancer Campus, Grand Paris, AstraZeneca
Non Small Cell Lung Cancer
03/16
03/16

Download Options